Neuro-Oncology Practice
Scope & Guideline
Exploring Complexities in Neurological Cancer
Introduction
Aims and Scopes
- Clinical Outcomes and Treatment Efficacy:
The journal focuses on the evaluation of clinical outcomes and treatment efficacy for various brain tumors, including gliomas, meningiomas, and brain metastases, utilizing both traditional and innovative therapeutic approaches. - Patient-Centered Care and Quality of Life:
Research emphasizing the importance of patient-reported outcomes, quality of life assessments, and supportive care measures is a core area, aiming to improve the overall experience and well-being of patients. - Neuropsychological and Cognitive Functioning:
The exploration of neuropsychological impacts, cognitive functioning, and rehabilitation strategies for brain tumor patients is a significant focus, reflecting the need for holistic care. - Health Disparities and Socioeconomic Factors:
The journal addresses socioeconomic disparities in access to care and treatment outcomes, highlighting the influence of social determinants on patient care in neuro-oncology. - Innovative Diagnostic and Therapeutic Techniques:
A commitment to disseminating advancements in diagnostic imaging, molecular profiling, and novel therapeutic strategies, including immunotherapy and targeted therapies, is evident. - Palliative Care Integration:
The integration of palliative care principles within neuro-oncology practice is a growing focus, emphasizing the need for comprehensive care throughout the disease trajectory.
Trending and Emerging
- Integration of Palliative Care:
There is a growing emphasis on integrating palliative care within neuro-oncology, focusing on quality of life, symptom management, and supportive interventions throughout the cancer continuum. - Impact of Socioeconomic Factors:
Recent studies increasingly explore the impact of socioeconomic factors and health disparities on treatment outcomes, reflecting a shift towards understanding how these elements affect patient care. - Neurocognitive Function and Rehabilitation:
Research on neurocognitive functioning and rehabilitation strategies for brain tumor survivors is trending, emphasizing the importance of cognitive health and quality of life post-treatment. - Patient-Reported Outcomes and Psychosocial Support:
A marked increase in the assessment of patient-reported outcomes and the psychosocial aspects of living with brain tumors highlights the importance of addressing emotional and psychological needs. - Molecular and Genetic Profiling:
There is a surge in studies focusing on molecular and genetic profiling of tumors, which is critical for personalizing treatment and understanding tumor biology. - Telemedicine and Remote Care Solutions:
The rise of telemedicine, particularly in response to the COVID-19 pandemic, has led to increased research on remote care solutions and their efficacy in neuro-oncology.
Declining or Waning
- Traditional Chemotherapy Protocols:
There appears to be a reduced emphasis on standard chemotherapy protocols for brain tumors, likely due to the increasing focus on personalized medicine and targeted therapies, which are seen as more effective. - Surgical Techniques with Limited Innovation:
As the field progresses with newer technologies and methodologies, traditional surgical techniques for brain tumors seem to receive less attention, indicating a shift towards more innovative approaches. - Generalized Neuro-Oncology Guidelines:
Research focusing on broad, generalized treatment guidelines without specific context or patient stratification is less prevalent, as the field moves towards more tailored and individualized treatment strategies. - Basic Epidemiological Studies:
There has been a noticeable decline in basic epidemiological studies that do not incorporate advanced methodologies or focus on specific subpopulations, as more targeted research gains traction. - Single-Institution Studies:
The prevalence of studies conducted within a single institution has decreased, with a shift towards multicenter collaborations and larger cohort studies to enhance the generalizability of findings.
Similar Journals
EUROPEAN JOURNAL OF HAEMATOLOGY
Transforming Hematology Through Rigorous ResearchEUROPEAN JOURNAL OF HAEMATOLOGY, published by Wiley, serves as a vital resource for experts in the field of hematology, focusing on the latest advancements in blood disorders and therapies. With an ISSN of 0902-4441 and an E-ISSN of 1600-0609, this esteemed journal has been disseminating knowledge since 1986 and continues to thrive, converging its visionary approach through to 2024. Notably, it holds a distinguished Q2 ranking in Hematology and an impressive Q1 ranking in the broader category of Medicine (miscellaneous) as of 2023, highlighting its significant contribution to the scientific community. With a Scopus rank of #45/137 and a 67th percentile in the field, the journal is recognized for its rigorous peer-reviewed research, making it an indispensable publication for researchers, practitioners, and students aiming to stay at the forefront of hematological studies. Though not an open-access journal, it ensures broad accessibility to critical findings via its subscription model, thus fostering an informed and globally engaged audience.
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE
Connecting Minds, Transforming Patient CareCESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
Shaping the Future of Orthopaedics Through Cutting-Edge ResearchClinical Orthopaedics and Related Research, published by Lippincott Williams & Wilkins, is a premier journal within the fields of orthopaedics and sports medicine, boasting a distinguished history since its inception in 1963. With an impressive impact factor and ranking within the top quartile (Q1) in multiple categories, including Medicine (miscellaneous), Orthopedics and Sports Medicine, Sports Science, and Surgery, this journal consistently delivers high-quality, peer-reviewed research that shapes contemporary practices and advancements in these critical areas. The journal is a vital resource for researchers, clinicians, and students, offering impactful studies and clinical trials that inform evidence-based practice and elevate the standards of patient care. With a strong commitment to the dissemination of innovative findings, Clinical Orthopaedics and Related Research serves as an essential platform for the exchange of ideas and discoveries that drive the future of orthopaedic health.
Journal of Korean Neurosurgical Society
Illuminating the Path in Neurosurgery and NeuroscienceThe Journal of Korean Neurosurgical Society, with its ISSN 2005-3711 and E-ISSN 1598-7876, stands as a paramount resource in the field of neurosurgery, bridging clinical practice and cutting-edge research in both neurology and multidisciplinary neuroscience. Published by the Korean Neurosurgical Society, this open-access journal has been committed to disseminating invaluable knowledge to the global scientific community since its establishment in 1972. Located in Seoul, South Korea, the journal underscores its prominence with impressive quartile rankings—Q3 in Neurology (Clinical), Q3 in Neuroscience (Miscellaneous), and Q2 in Surgery for 2023. Its standing in Scopus rankings further emphasizes its impact, with a ranking of #195/551 in Medicine: Surgery and #235/400 in Medicine: Neurology (Clinical). By fostering a platform for innovative findings and advancements in surgical techniques, the Journal of Korean Neurosurgical Society aims to support professionals, researchers, and students alike in their pursuit of excellence and knowledge in neurosurgery and related fields, ensuring a brighter future for patient care and scientific inquiry.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
Uniting researchers and practitioners for a healthier future.Pediatric Hematology and Oncology, published by Taylor & Francis Inc, serves as a vital platform dedicated to the fields of hematology, oncology, and pediatrics, providing a comprehensive avenue for the dissemination of scholarly research and clinical advancements. With an ISSN of 0888-0018 and an E-ISSN of 1521-0669, this journal has successfully converged its expertise over the years from 1984 to 2024. Ranked in the Q3 category for Hematology and Oncology, alongside a Q2 ranking in Pediatrics, Perinatology, and Child Health (2023), it engages a diverse readership comprising researchers, healthcare professionals, and students eager to explore groundbreaking studies in child health and treatment methodologies. While it currently does not offer Open Access options, the journal is widely cited and recognized, particularly in its specialized fields, fostering a rich environment for dialogue and innovation in the management of pediatric hematological and oncological disorders. The journal is based in the United Kingdom at 530 Walnut Street, Ste 850, Philadelphia, PA 19106, making it an essential resource for those pursuing excellence in pediatric medical research.
Onkologie
Empowering Clinicians with Cutting-Edge Insights in Hematology.Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.
Case Reports in Oncological Medicine
Innovating cancer treatment through real-world experiences.Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.
BREAST
Advancing breast health through cutting-edge research.BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.
JNCI Cancer Spectrum
Advancing cancer research for a brighter tomorrow.JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.
TRENDS IN CARDIOVASCULAR MEDICINE
Connecting Research with Real-World ImpactTRENDS IN CARDIOVASCULAR MEDICINE, published by Elsevier Science London, stands at the forefront of the cardiology field, with a commendable Q1 ranking in the category of Cardiology and Cardiovascular Medicine. Since its inception in 1991, this esteemed journal has provided a vital platform for disseminating cutting-edge research and innovative clinical practices, reflecting the dynamic developments in cardiovascular health. With an impact factor positioning it among the top 3% in its category, TRENDS IN CARDIOVASCULAR MEDICINE is essential reading for researchers, healthcare professionals, and students pursuing the latest advancements and evidence-based approaches in cardiology. Although this journal does not currently operate under an open-access model, its rich array of content encompasses a variety of topics from clinical studies to reviews, ensuring readers stay informed on the pivotal trends that shape cardiovascular medicine. This commitment to excellence underscores the journal's role as a premier resource for anyone dedicated to improving cardiovascular health.